Last Price | 0.89 | Max Price | 0.89 |
Min Price | 0.89 | 1 Year return | -29.92 |
Avg. Target | 0.00 | Expected Return | -100.00 % |
Sector | Health Care | Subsector | Biotechnology |
Sell | 0 | Rating | |
Hold | 0 | Concensus | |
Buy | 0 | ||
Annual report 2017 |
Contact info:Street: 8440 Allison Pointe Boulevard, Suite 100,City: IndianapolisCountry: BelgiumWebsite: www.acaciapharma.com
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 0 | 141,925 | 0.00 % |
2020 | 0 | 170,231 | 0.00 % |
2021 | 0 | 252,886 | 0.00 % |
2022 | 1 | 238,500 | 0.00 % |
2023 | 0 | 0 | 0.00 % |
Date Label | Bank Label | Stock Label | Advice Label | Price Label | Diff Label |
---|---|---|---|---|---|
October 03, 2021 | Jefferies & Co. | Acacia Pharma | Buy | 7.00 | 87.29 % |
July 03, 2020 | DeGroof Petercam | Acacia Pharma | Buy | 6.20 | 85.65 % |
No Records Found
2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|
No Records Found
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
0
|
0
|
0
|
0
|
0
|
|
Costs |
0
|
20
|
18
|
8
|
21
|
23
|
Profit |
0
|
-20
|
-18
|
-8
|
-21
|
-23
|
Margin of profit |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
ROI |
0.0
|
477.43
|
125.83
|
33.08
|
-83.94
|
-525.06
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
0
|
-4
|
-14
|
-24
|
25
|
4
|
Debt |
0
|
16
|
27
|
29
|
14
|
14
|
Total assets |
0
|
12
|
13
|
5
|
39
|
19
|
Solvency |
0.0
|
-35.09
|
-114.92
|
-497.52
|
63.66
|
23.30
|
Cash |
0
|
8
|
8
|
4
|
37
|
17
|
Cashflow |
0
|
-15
|
-14
|
-5
|
-16
|
-20
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
0.0
|
-0.94
|
-0.51
|
-0.17
|
-1.10
|
-1.38
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
0.0
|
0.0
|
0.0
|
1.28
|
2.11
|
Eps |
-0.37
|
-0.34
|
-0.15
|
-0.47
|
-0.43
|
Price/earnings-ratio |
0.0
|
0.0
|
0.0
|
-2.72
|
-2.07
|
Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
Book value |
-0.08
|
-0.27
|
-0.45
|
0.46
|
0.08
|
Market to book |
0.0
|
0.0
|
0.0
|
0.36
|
0.09
|
Cashflow per stock |
-0.28
|
-0.26
|
-0.09
|
-0.29
|
-0.36
|
Stocks |
53
|
53
|
53
|
53
|
55
|
Market Cap |
0.00
|
0.00
|
0.00
|
68.26
|
48.85
|
Date
|
Price
|
---|---|
22 Mar 2024
|
0.89
|
18 Mar 2024
|
0.89
|
15 Mar 2024
|
0.89
|
12 Mar 2024
|
0.89
|
11 Mar 2024
|
0.89
|
09 Mar 2024
|
0.89
|
07 Mar 2024
|
0.89
|
01 Mar 2024
|
0.89
|
29 Feb 2024
|
0.89
|
27 Feb 2024
|
0.89
|
22 Feb 2024
|
0.89
|
21 Feb 2024
|
0.89
|
20 Feb 2024
|
0.89
|
15 Feb 2024
|
0.89
|
14 Feb 2024
|
0.89
|
13 Feb 2024
|
0.89
|
09 Feb 2024
|
0.89
|
08 Feb 2024
|
0.89
|
07 Feb 2024
|
0.89
|
06 Feb 2024
|
0.89
|
05 Feb 2024
|
0.89
|
01 Feb 2024
|
0.89
|
31 Jan 2024
|
0.89
|
30 Jan 2024
|
0.89
|
27 Jan 2024
|
0.89
|
25 Jan 2024
|
0.89
|
24 Jan 2024
|
0.89
|
23 Jan 2024
|
0.89
|
16 Jan 2024
|
0.89
|
11 Jan 2024
|
0.89
|